These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10687857)

  • 21. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A de novo mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone.
    Lado-Abeal J; Dumitrescu AM; Liao XH; Cohen RN; Pohlenz J; Weiss RE; Lebrethon MC; Verloes A; Refetoff S
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1760-7. PubMed ID: 15598685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel point mutation (R243Q) in exon 7 of the c-erbA beta thyroid hormone receptor gene in a family with resistance to thyroid hormone.
    Onigata K; Yagi H; Sakurai A; Nagashima T; Nomura Y; Nagashima K; Hashizume K; Morikawa A
    Thyroid; 1995 Oct; 5(5):355-8. PubMed ID: 8563471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
    Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
    Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
    Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.
    Reutrakul S; Sadow PM; Pannain S; Pohlenz J; Carvalho GA; Macchia PE; Weiss RE; Refetoff S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3609-17. PubMed ID: 11061510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TR surfaces and conformations required to bind nuclear receptor corepressor.
    Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
    Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal domain of thyroid hormone receptor-alpha is required for its biological activities.
    Thuestad G; Kraus I; Apriletti J; Saatcioglu F
    DNA Cell Biol; 2000 Jul; 19(7):389-99. PubMed ID: 10945229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.
    Sarkissian G; Dace A; Mesmacque A; Bony-Trifunovic H; Malezet-Desmoulins C; Torresani J; Margotat A
    Thyroid; 1999 Feb; 9(2):165-71. PubMed ID: 10090317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release.
    Lin BC; Hong SH; Krig S; Yoh SM; Privalsky ML
    Mol Cell Biol; 1997 Oct; 17(10):6131-8. PubMed ID: 9315673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation of thyroid hormone receptor beta (I431V) impairs corepressor release, and induces thyroid hormone resistance syndrome.
    Ferreira Azevedo M; Barra GB; Medeiros LD; Simeoni LA; Naves LA; Neves Fde A
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1304-12. PubMed ID: 19169485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action.
    Kopp P; Kitajima K; Jameson JL
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):49-61. PubMed ID: 8594618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of resistance to thyroid hormone (RTH).
    Nagaya T; Seo H
    Endocr J; 1998 Dec; 45(6):709-18. PubMed ID: 10395225
    [No Abstract]   [Full Text] [Related]  

  • 36. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
    Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M
    Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.
    Hu X; Lazar MA
    Nature; 1999 Nov; 402(6757):93-6. PubMed ID: 10573424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
    Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavaillès V; Kalkhoven E; Matthews C; Nystrom E; Stenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VK
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):248-53. PubMed ID: 8990194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition.
    Nagaya T; Fujieda M; Seo H
    Biochem Biophys Res Commun; 1998 Jun; 247(3):620-3. PubMed ID: 9647743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.